|Elidel||pimecrolimus||Brand||United Kingdom||1%-30G||1 Pack||DR||$77.54||Add|
|Elidel||pimecrolimus||Brand||United Kingdom||1%-60G||1 Pack||DR||$130.10||Add|
|Elidel||pimecrolimus||Brand||United Kingdom||1%-100G||1 Pack||DR||$183.98||Add|
|Elidel Cream||pimecrolimus||Brand||India||1%w/w||1 Cream||DR||$55.64||Add|
|Elidel Cream||pimecrolimus||Brand||India||1%w/w||1 Cream X 10||DR||$506.40||Add|
|Elidel||pimecrolimus||Brand||New Zealand||1%-15G||1 Pack||RX||$40.02||Add|
|Elidel||pimecrolimus||Brand||New Zealand||1%-30G||1 EA||RX||$97.00||Add|
|Elidel||pimecrolimus||Brand||United Kingdom||1%-30G||2 shipments of 1 Pack||DR||$179.06||Add|
|Elidel||pimecrolimus||Brand||United Kingdom||1%-60G||2 shipments of 1 Pack||DR||$284.18||Add|
Medicines have benefits and some have risks. Always read the label and use only as directed. If symptoms persist or you have side effects see your health professional. Brands and generics both contain the same active ingredient(s) and are medically equivalent. Some brands are marketed under different names by the same manufacturer depending on the country of origin. Images are provided as a reference only, the received medicine may vary in packaging, color, pill shape, etc, from one batch to the next. For an item marked "generic" any quality brand may be sent, however you will always receive the active ingredients ordered in the strength(s) ordered.
Ships from the UK with tracking in 2-3 weeks
Elidel Cream (pimecrolimus) is a topical immunosuppressive medication, useful in a range of inflammatory skin conditions. It can be used in patients age 2 and up.
This product is marketed toward treating atopic dermatitis, also known as eczema. It is a second-line treatment, meaning it should be used only when other treatments fail to work or can't be used, such as due to patient allergies.
Off-label patients use Elidel to treat a number of other skin conditions, such as:
The medication may be used for other inflammatory skin conditions as well. Treatment is usually quite similar in all cases; the cream is applied directly to the affected area twice per day until the condition is cleared up. Treatment with Elidel should be short-term, ending when the condition is resolved. Treatment can be repeated if the condition resurfaces in the future.
In addition to using Elidel, triggers should be avoided to as great an extent as possible. Common triggers include:
Moisturizers can be applied to the skin after Elidel has been absorbed, usually after 15 to 30 minutes. Avoid covering medicated areas with airtight dressings. Also avoid showering, bathing, or swimming for a few hours after applying Elidel; the medication washes off easily.
As an immunosuppresive medication it is known that Elidel inhibits the immune system, thus inhibiting the inflammatory reaction of the body that causes itching, inflammation, warmth, pain, and other symptoms. It is not clear how exactly the medication works in clearing up skin lesions.
If significant results are not seen within 6 weeks of use, alternative treatments should be considered. It's possible that the condition was misdiagnosed.
Warnings & Side Effects
Not everyone is a good candidate for Elidel; in particular those who have the following should speak with a doctor about risks and warning signs before use:
As an immunosuppresive medication, Elidel can interfere with the body's healing process when other infections are present, including those that don't impact the skin. It can also make patients more sensitive to light; patients will need to avoid sun lamps, tanning beds, ultraviolet light therapy, and prolonged sun exposure during treatment.
Otherwise, side effects are unlikely beyond the basic mild burning at the application site during the first few applications. This isn't a problem unless it becomes severe or persists beyond the first few days.
Allergic reactions are always a possibility; warning signs include swelling, particularly of the face or throat; severe dizziness; confusion; difficulty breathing; and a new or worsening rash on the skin.
The USA's regulatory agency, the FDA, has ordered a black-box warning on Elidel packages that the product increases risk of lymph node cancer or skin cancer. This a very disputed topic, with other regulatory agencies and medical associations---including many in the USA---stating there is no evidence to support the FDA's claims.
The effects of Elidel on unborn or nursing babies are unclear; women who are pregnant or breastfeeding should avoid use unless the benefits outweigh any potential risks.